Julie Lorber entered the industry of Internal Medicine Doctors in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.
To acquire more information, please contact Julie Lorber by calling (618) 526-8430 during business hours. You can also write to the business’ Single Location at 9515 Holy Cross Lane, Breese, Illinois IL 62230. You can also visit the company’s website at stjoebreese.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Julie Lorber |
Representative: | Julie Lorber |
Place of Business: | 9515 Holy Cross Lane, Breese, IL 62230 |
Contact Number: | (618) 526-8430 |
Website: | stjoebreese.com |
Type of Service: | Internal Medicine Doctors |
SIC Number: | 8011 |
NAICS Number: | 621111 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2010 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Julie Lorber is a company operating from Clinton, Illinois providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 621111 as Internal Medicine Doctors.
With a current employee count of 1 to 4, Julie Lorber has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Julie Lorber at (618) 526-8430 for related queries, or to locate its Single Location using the coordinates 38.625294,-89.524475.
The Single Location can also be found at the street address 9515 Holy Cross Lane in Breese, Illinois 62230 and can be engaged online through the company website at stjoebreese.com, the company Twitter , and Facebook page .